CorVel Corporation (NasdaqGS:CRVL) have seen a year over year change of sales growth of 0.04263. The 1488960 market value company based out of United States of America is an important player in the Health Care Equipment & Services sector.
While sales growth can be a key driver for a company’s stock performance, there are many other factors to consider as well. Here we’ll take a look at several other notable indicators.
Investors are usually scouring the markets for that next great stock pick. Locating that special winner to jumpstart the portfolio may involve lots of diligent hard work. Filing through the massive amounts of data regarding public companies can be an overwhelming task. Many successful investors will approach the equity markets from various sides. This may include keeping a close eye on the fundamentals as well as the technical data. This may also include following sell-side analyst opinions and tracking what the big money institutions are buying or selling.
So how has CorVel Corporation (NasdaqGS:CRVL) performed in terms of returns? The ROIC quality score stands at 16.278418 whilet he actual return on invested capital holds at 0.246569. CorVel Corporation’s book to market ratio is at 0.136886 while the book to market mean difference is -0.04652. This indicator tells you how a company is currently valued in terms of Book to Market compared to its average Book to Market over the past 10 years. It’s important to note that BM is the inverse of the Price to book ratio. Thus a high BM ratio means a company is undervalued.
In glancing at some key ratios we note that the Piotroski F-Score is at 6 (1 to 10 scale) and the ERP5 rank is at 6444. The Q.I. Value of CorVel Corporation (NasdaqGS:CRVL) currently reads 40.00000 on the Quant scale. The Free Cash Flow score of 1.190801 is also swinging some momentum at investors. The United States of America based firm is currently valued at 4736.
Some other notable ratios include the Accrual Ratio of 0.784348, the Altman Z score of 6.789167, a Montier C-Score of 3.00000 and a Value Composite rank of 58.
In looking at some Debt ratios, CorVel Corporation (NasdaqGS:CRVL) currently has a debt to equity ratio of 0.50295 and a Free Cash Flow to Debt ratio of 0.603459. This ratio gives insight as to how high the firm’s total debt is compared to its free cash flow generated. In terms of Net Debt to EBIT, that ratio stands at -0.03018. This ratio reveals how easily a firm is able to pay interest and capital on its net outstanding debt. The lower the ratio the better as that indicates that the company is able to meet its interest and capital payments. Lastly we’ll take note of the Net Debt to Market Value ratio. CorVel Corporation’s ND to MV current stands at -0.001287. This ratio is calculated as follows: Net debt (Total debt minus Cash ) / Market value of the company.
Investors are frequently looking for any possible way to get a leg up in the market. This may involve committing to plan that will hopefully outperform the market and maximize profits. Many investors will choose to employ top-down analysis. Top-down analysis involves examining the big picture of the economy and the world of finance. After studying global economic conditions, investors may then analyze different sectors that are possibly well positioned to beat the market. After identifying the sector or sectors, investors may then do further analysis of stocks within the specific industry in order to find firms that are successful and primed for growth. Other individual investors may choose to go with bottom-up analysis when looking for stock to add to the portfolio. The bottom-up approach takes the emphasis off of the power and significance of market and economic cycles. Investors may focus on individual companies and not worry so much about the specific industry or economy in general.
CorVel Corporation (NasdaqGS:CRVL) are showing an adjusted slope average of the past 125 and 250 days of 15.19207. The Adjusted Slope 125/250d indicator is equal to the average annualized exponential regression slope, over the past 125 and 250 trading days, multiplied by the coefficient of determination (R2). The purpose of this calculation is to provide a longer term average adjusted slope value that levels out large share price movements by using the average. This indicator is useful in helping find stocks that have been on a smooth upward trend over the past 6 months to a year.
Drilling down into some additional key near-term indicators we note that the Capex to PPE ratio stands at 0.123305 for CorVel Corporation (NasdaqGS:CRVL). The Capex to PPE ratio shows you how capital intensive a company is. Stocks with an increasing (year over year) ratio may be moving to be more capital intensive and often underperform the market. Higher Capex also often means lower Free Cash Flow (Operating cash flow – Capex) generation and lower dividends as companies don’t have the cash to pay dividends if they are investing more in the business.
From time to time, investors may need to decide when to sell a winner. This can be one of the tougher portfolio decisions to make.
When dealing with the equity markets, investors are often tasked with trying to find stocks that are bound for glory. Every investor dreams of finding those stocks that were overlooked but are poised to pick up momentum. New investors are often instructed to set goals before starting to invest. Creating attainable, realistic goals can be a good starting point before digging into the investment trenches. After setting up goals considering financial status, objectives, timeframes and risk appetite, the next step may involve creating an actionable plan. Once the plan is in place, it may be extremely important to routinely monitor the performance of the portfolio. There are often many well crafted investment plans that for whatever reason don’t seem to be working out properly. Being able to evaluate and adjust the plan based on market activity may end up being the difference between a winning or losing portfolio. Being able to adapt to the fast paced and often times tumultuous market landscape can be a gigantic benefit for long-term portfolio health.